DRIPTANE

Medicinal product

(Invented) name

DRIPTANE

Active substance (s)

Oksibutinino hidrochloridas

Strength

5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BD04, Oxybutynin

Marketing authorisation holder

Viatris SIA, Latvija

Date of authorisation

1997-06-06

Date of renewal

2011-02-09

Documents

2321 Pakuotės lapelis 2023 09 01.docx

2321 DRIPTANE 5mg tab RPP 2023 09 01.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Oksibutinino hidrochloridas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
4667	680	1000680	lizdinė plokštelė	N60		Receptinis	LT/1/97/2321/001	Netiekiama	2025-01-30	2025-03-15	No	-	-	Download

Stadijos

Data	Stadija
2011-02-09	Perregistruotas
1997-06-06	Registruotas